Characterization of a recombinant herpes simplex virus 1 designed to enter cells via the IL13Rα2 receptor of malignant glioma cells

Journal of Virology

Volumn 79, Issue 9, 2005, Pages 5272-5277

  Zhou, Guoying ^a   Roizman, Bernard ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; GLYCOPROTEIN B; HEPARAN SULFATE; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 13 RECEPTOR ALPHA2; INTERLEUKIN 2; INTERLEUKIN 4; LIGAND; PROTEIN C; VIRUS RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL CULTURE; CELL DIVISION; CELL SURFACE; CONTROLLED STUDY; ENDOCYTOSIS; GENE DELETION; GENE EXPRESSION; GENETIC TRANSDUCTION; GLIOMA CELL; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IN VITRO STUDY; MUTANT; NONHUMAN; PLASMID; PRIORITY JOURNAL; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS TRANSMISSION; WILD TYPE;

ANIMALS; CELL LINE; CELL LINE, TUMOR; GENE DELETION; GLIOMA; HEPARITIN SULFATE; HERPESVIRUS 1, HUMAN; HUMANS; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-13; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; RECEPTORS, VIRUS; RECOMBINATION, GENETIC; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

BOVINAE; CRICETINAE; HERPES; HUMAN HERPESVIRUS 1;

EID: 17444385274     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.9.5272-5277.2005     Document Type: Article

References (25)

1. Anderson, D. B., S. Laquerre, K. Ghosh, H. P. Ghosh, W. F. Goins, J. B Cohen, and J. C. Glorioso. 2000. Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry. J. Virol. 74:2481-2487.
2. 134.5 genes precludes shutoff of protein synthesis by blocking the phosphorylation of eIF-2α. J. Virol. 72:7005-7011.
3. 134.5- mutants of herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 92:10516-10520.
4. Cocchi, F., L. Menotti, P. Mirandola, M. Lopez, and G. Campadelli-Fiume. 1998. The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cells. J. Virol. 72:9992-10002.
5. Debinski, W. 1998. An immune regulatory cytokine receptor and glioblastoma multiforme: an unexpected link. Crit. Rev. Oncog. 9:255-268.
6. Debinski, W., and D. M. Gibo. 2000. Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer/testis antigen. Mol. Med. 6:440-449.
7. Debinski, W., D. M. Gibo, S. W. Hulet, J. R. Connor, and G. Y. Gillespie. 1999. Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas. Clin. Cancer Res. 5:985-990.
8. Downey, G. P., J. R. Butler, H. Tapper, L. Fialkow, A. R. Saltiel, B. B. Rubin, and S. Grinstein. 1998. Importance of MEK in neutrophil microbicidal responsiveness. J. Immunol. 160:434-443.
9. Geraghty, R. J., C. Krummenacher, G. H. Cohen, R. J. Eisenberg, and P. G. Spear. 1998. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280:1618-1620.
10. Haugh, J. M., A. C. Huang, H. S. Wiley, A. Well, and D. A. Lauffenburger. 1999. Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts. J. Biol. Chem. 274:34350-34360.
11. - herpes simplex virus 1: failure of activated RNA-dependent protein kinase to shut off protein synthesis is associated with a deletion in the domain of the α47 gene. J. Virol. 71:6049-6054.
12. 134.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1α to dephosphorylate the α subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 94:843-848.
13. Laquerre, S., D. B. Anderson, D. B. Stolz, and J. C. Glorioso. 1998. Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells. J. Virol. 72:9683-9697.
14. Louis, D. N., S. L. Pomeroy, and J. G. Cairncross. 2002. Focus on central nervous system neoplasia. Cancer Cell. 1:125-128.
15. Markert, J. M., M. D. Medlock, S. D. Rabkin, G. Y. Gillespie, T. Todo, W. D. Hunter C. A. Palmer, F. Feigenbaum, C. Tornatore, F. Tufaro, and R. L. Martuza. 2000. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther. 7:867-874.
16. Mineta, T., S. D. Rabkin, T. Yazaki, W. D. Hunter, and R. L. Martuza. 1995. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat. Med. 1:938-943.
17. Mintz, A., D. M. Gibo, B. Slagle-Webb, N. D. Christensen, and W. Debinski. 2002. IL-13R7alpha;2 is a glioma-restricted receptor for interleukin-13. Neoplasia 4:388-399.
18. Mohr, I., and Y. Gluzman. 1996. A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function. EMBO J. 15:4759-4766.
19. Montgomery, R. I., M. S. Warner, B. J. Lum, and P. G. Spear. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/ NGF receptor family. Cell 87:427-436.
20. Pandita, A., K. D. Aldape, G. Zadeh, A. Guha, and C. D. James. 2004. Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR. Genes Chromosomes Cancer 39:29-36.
21. Papanastassiou, V., R. Rampling, M. Frazer, R. Petty, H. Haddley, J. Nicoll, J. Harland, R. Mabbs, and M. Brown. 2002. The potential for efficacy of the modified (ICP34.5-) herpes simplex virus HSV1716 following intratumoral injection into human malignant glioma: a proof of principle study. Gene Ther. 9:398-406.
22. Roizman, B., and D. M. Knipe. 2001. The replication of herpes simplex viruses. In D. M. Knipe, P. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed., p.2399-2459. Lippincott-Williams and Wilkins, New York, N.Y.
23. Shukla, D., J. Liu, P. Blaiklock, N. W. Shworak, X. Bai, J. D. Esko, G. H. Cohen, R. J. Eisenberg, R. D. Rosenberg, and P. G. Spear. 1999. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99:13-22.
24. Zhou, G., G. J. Ye, W. Debinski, and B. Roizman. 2002. Engineered herpes simplex virus 1 is dependent on IL13Rα2 receptor for cell entry and independent of glycoprotein D receptor interaction. Proc. Natl. Acad. Sci. USA 99:15124-15129.
25. Zhou, G., V. Galvan, G. Campadelli-Fiume, and B. Roizman. 2000. Glycoprotein D or J delivered in trans blocks apoptosis in SK-N-SH cells induced by a herpes simplex virus 1 mutant lacking intact genes expressing both glycoproteins. J. Virol. 74:11782-11791.